Article View: sci.med.pharmacy
Article #136Re: The myth about Rohypnol and GHB in rape,in North-America
From: Peter S. Saly
Date: Wed, 02 Jun 1999 00:00
Date: Wed, 02 Jun 1999 00:00
54 lines
3026 bytes
3026 bytes
Contre les Diabolisations <patanie@pasdepub.com> wrote in article <375472d0.5409851@nn-tk004.ocn.ad.jp>... > One of the main economical manipulation technique of big industries,in > the USA,against their foreigne concurrents is to demonise them with > completely fabricated propaganda. > > The cases of fabrications of propaganda are numerous. Here is a > stastic which clearly demonstrates the fabrication of lies by the US. > FDA and the US. media gainst 2 european products: > > Rohypnol > Gamma-OH(GHB,sodium oxybate,Xyrem,etc) > > See below: > > Results of a 2-1/2 year study by Dr. ElSohly were published in the > May-June issue of the Journal of Analytical Toxicology. The results > continue to be consistent over time in terms of drug prevalence. > > Test results for the period 6/96 through 2/99 were as follows: > > Total samples 2003 > > Alcohol 820 > Marijuana 363 > Other benzos 270 > Cocaine 166 > Amphetamines 140 > GHB 67 <------------------ > Opiates 50 > Propoxyphene 24 > Barbiturates 22 > Flunitrazepam(Rohypnol) 7 <------------------ > Phencyclidine 1 > > 35% of positive samples contained more than one substance. Four of the > seven flunitrazepam samples contained other substances such as cocaine > and morphine. > > All samples were submitted by law enforcement agencies, university > health centers, rape crisis centers and hospital emergency > departments. In all cases, the samples were collected from people who > believed they were victims of substance-related sexual assault. > > 98% of the samples were collected within 72 hours of ingestion of > suspected substances. > > Dr. ElSohly published his method for GC/MS testing of flunitrazepam - > with a cutoff of one nanogram per milliliter - in the Sept. 1997 issue > of the Journal of Analytical Toxicology. > >
Technical Details
Message-ID:
<01beacb2$37ff7fc0$df8ceed0@alys-01>Path:
arc1-ca.pugleaf.net!unknown!not-for-mailReferences:
<375472d0.5409851@nn-tk004.ocn.ad.jp>Show Full Headers
Complete Article Headers
X-Google-Language: ENGLISH,ASCII-7-bit X-Google-Thread: 101dc0,2ea2550c25dddba7 X-Google-Attributes: gid101dc0,public X-Google-Thread: f4552,2ea2550c25dddba7 X-Google-Attributes: gidf4552,public X-Google-Thread: f5f6d,2ea2550c25dddba7 X-Google-Attributes: gidf5f6d,public X-Google-Thread: 1045ed,2ea2550c25dddba7 X-Google-Attributes: gid1045ed,public X-Google-Thread: fc9c6,2ea2550c25dddba7 X-Google-Attributes: gidfc9c6,public X-Google-Thread: 10cf66,2ea2550c25dddba7 X-Google-Attributes: gid10cf66,public From: "Peter S. Saly" <Peter@Saly.com> Subject: Re: The myth about Rohypnol and GHB in rape,in North-America Date: 1999/06/02 Message-ID: <01beacb2$37ff7fc0$df8ceed0@alys-01> X-Deja-AN: 484737924 References: <375472d0.5409851@nn-tk004.ocn.ad.jp> X-Complaints-To: newsabuse@remarQ.com X-Trace: 928298612 SRKRDJGII8964D0EEC usenet57.supernews.com Organization: Alys Analogs Inc. Newsgroups: sci.med.pharmacy,bionet.neuroscience,alt.support.depression,soc.culture.swiss,fr.soc.politique,qc.politique